Can We Improve the Quality of Care at the End of Life in Israel? (ISRAEOLC)
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT02129283|
Recruitment Status : Unknown
Verified April 2014 by Hadassah Medical Organization.
Recruitment status was: Not yet recruiting
First Posted : May 2, 2014
Last Update Posted : May 2, 2014
|Condition or disease||Intervention/treatment||Phase|
|End of Life Process||Behavioral: Simulation training||Not Applicable|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||300 participants|
|Intervention Model:||Parallel Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Health Services Research|
|Official Title:||Can We Improve the Quality of Care at the End of Life in Israel?|
|Study Start Date :||May 2014|
|Estimated Primary Completion Date :||May 2016|
|Estimated Study Completion Date :||May 2017|
Experimental: Simulation training
End-of-life simulation training of critical care physicians and nurses using standardized patients to improve communication and interpersonal skills.
Behavioral: Simulation training
End-of-life simulation training. The simulation training will include training with standardized patients (actors) using 9 essential skills for communication and interpersonal relationships. The control group will have no training.
No Intervention: Control
No simulation training
- Change in ICU care process in an ICU from baseline [ Time Frame: 3-6 months and 12 months post-training ]Additional information about the outcome measure- Other parameters for ICU care process include physician or nurse asking about patient preferences, documentation of patient and/or surrogate preferences, documented family conferences, receiving CPR, ventilation, vasopressors or dialysis, deaths preceded by DNRs, limitations of life-sustaining treatments or CPR, time from ICU admission to first discussion about limitations, to DNR and to death and time from first discussion about limitations until death.
- Change in Family satisfaction in an ICU from baseline [ Time Frame: 3-6 months and 12 months post-training ]Additional information about the outcome measure- Other parameters for family satisfaction iclude- adequate time for asking questions, expressing fears and emotions, emotional support , compassion shown to family, supporting family decisions, consideration of family needs, achieving appropriate level of care and perceptions of the quality of palliative care and quality of death and dying.
- Change in Teamwork in an ICU from baseline [ Time Frame: 3-6 months and 12 months post-training ]Additional information about the outcome measure- Other parameters for teamwork include family conflicts, inappropriateness of care, decisions shared by nurses and physicians, nurse involvement in EOL decisions and work autonomy.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02129283
|Contact: Charles L Sprung, MD||972 2 677 email@example.com|
|Hadassah Hebrew University Medical Center||Not yet recruiting|
|Jerusalem, Israel, 91120|
|Contact: Charles L Sprung, MD 972 2 677 8060 firstname.lastname@example.org|
|Study Chair:||Charles L Sprung, MD||Hadassah Medical Organization|
|Principal Investigator:||Amiram Lev, MD||Afula Hospital, Afula, Israel|
|Principal Investigator:||Moti Klein, MD||Soroka Hospital, Beer Sheva|
|Principal Investigator:||Nimrod Adi||Kaplan Hospital, Rechovot, Israel|
|Principal Investigator:||Pierre Singer, MD||Beilinson Hospital, Petach Tikva,Israel|
|Principal Investigator:||Arik Eden, MD||Carmel Hospital, Haifa, Israel|
|Principal Investigator:||Nissim Yifrach, MD||Meir Hospital, Kfar Saba, Israel|
|Principal Investigator:||Shaul Lev, MD||Sharon Hospital, Herzilia, Israel|
|Principal Investigator:||Amitai Ziv, MD||Israel Center for Medical Simulation (MSR), The Sheba Medical Center, Tel Hashomer , Ramat Gan, Israel|
|Principal Investigator:||Yigal Shoshan, MD||Hadassah Medical Organization|
|Principal Investigator:||Mayer Brezis, MD||Hadassah Medical Organization|
|Principal Investigator:||Eyal Jacobson, MD||Ministry of Health, Israel|